These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8521681)

  • 41. Sonographic sign for the detection of early fetal ascites in the management of severe isoimmune disease without intrauterine transfusion.
    Benacerraf BR; Frigoletto FD
    Am J Obstet Gynecol; 1985 Aug; 152(8):1039-41. PubMed ID: 3927735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fetal blood transfusion.
    Ryan G; Morrow RJ
    Clin Perinatol; 1994 Sep; 21(3):573-89. PubMed ID: 7982335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Analysis of the ferritin level of the amniotic fluid in the diagnosis of Rh isoimmunization].
    Debski R; Kokocińska D; Korzycki J; Marianowski L
    Acta Haematol Pol; 1988; 19(3-4):169-75. PubMed ID: 3150891
    [No Abstract]   [Full Text] [Related]  

  • 44. Increasing the noninvasive management of rhesus isoimmunization.
    Papantoniou N; Daskalakis G; Anastasakis E; Marinopoulos S; Mesogitis S; Antsaklis A
    Int J Gynaecol Obstet; 2008 Jun; 101(3):281-4. PubMed ID: 18272156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasmapheresis and intravenous immune globulin for the treatment of D alloimmunization in pregnancy.
    Novak DJ; Tyler LN; Reddy RL; Barsoom MJ
    J Clin Apher; 2008; 23(6):183-5. PubMed ID: 19003884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence of Rhesus isoimmunization in Rhesus-negative mothers in Ramadi, Iraq, in the mid-1990s.
    al-Joudi FS; Ahmed al-Salih SA
    East Mediterr Health J; 2000; 6(5-6):1122-5. PubMed ID: 12197338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline #8: the fetus at risk for anemia--diagnosis and management.
    ; Mari G; Norton ME; Stone J; Berghella V; Sciscione AC; Tate D; Schenone MH
    Am J Obstet Gynecol; 2015 Jun; 212(6):697-710. PubMed ID: 25824811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [THE FETAL MIDDLE CEREBRAL ARTERY PEAK SYSTOLIC VELOCITY AS A PEDICTOR OF FETAL ANEMIA IN RH-ALLOIMMUNIZED PREGNANCY].
    Markov D; Pavlova E; Atanassova D; Diavolov V; Hitrova S; Vakrilova L; Pramatarova T; Slancheva B; Ivanov S
    Akush Ginekol (Sofiia); 2015; 54(4):67-72. PubMed ID: 26410952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
    Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
    Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rhesus isoimmunization.
    Plevyak MP; Carr SR
    Med Health R I; 2001 May; 84(5):148-51. PubMed ID: 11392951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of pregnancies complicated by anti-c isoimmunization.
    Hackney DN; Knudtson EJ; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2004 Jan; 103(1):24-30. PubMed ID: 14704240
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Diagnostic evaluation of Rh isoimmunization (clinical data)].
    Pozowski J; Cekański A; Poreba R; Kolny L
    Ginekol Pol; 1987 Jul; 58(7):439-44. PubMed ID: 3121451
    [No Abstract]   [Full Text] [Related]  

  • 53. Rhesus disease: the model for fetal therapy.
    Nicolaides KH; Rodeck CH
    Br J Hosp Med; 1985 Sep; 34(3):141-8. PubMed ID: 3933599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determination of optimal timing of serial in-utero transfusions in red-cell alloimmunization.
    Friszer S; Maisonneuve E; Macé G; Castaigne V; Cortey A; Mailloux A; Pernot F; Carbonne B
    Ultrasound Obstet Gynecol; 2015 Nov; 46(5):600-5. PubMed ID: 25523966
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Use of ultrasound in intrauterine fetal transfusion: presentation of a case].
    Amor Calleja L; García Alonso A; García Tagle JE; Osorno Covarrubias LR
    Ginecol Obstet Mex; 1985 Dec; 53():319-25. PubMed ID: 3939221
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comparative analysis of the effects to date of the prevention of Rh incompatibility].
    Jedwabny A; Suchocki S; Bobrowska G
    Acta Haematol Pol; 1988; 19(1-2):56-8. PubMed ID: 2853507
    [No Abstract]   [Full Text] [Related]  

  • 57. The prognosis of Rh-affected pregnancies: an exception to the usual rule.
    Perkins RP
    Am J Perinatol; 1988 Jan; 5(1):57-60. PubMed ID: 3122780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent developments in fetal medicine.
    Kumar S; O'Brien A
    BMJ; 2004 Apr; 328(7446):1002-6. PubMed ID: 15105327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnosing hemolytic disease of the fetus--time to put the needles away?
    Moise KJ
    N Engl J Med; 2006 Jul; 355(2):192-4. PubMed ID: 16837685
    [No Abstract]   [Full Text] [Related]  

  • 60. [Intrauterine rhesus diagnosis].
    Herrmann U
    Beitr Infusionsther; 1989; 24():214-20. PubMed ID: 2481541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.